Високо
без
100 години вече
развиваме и произвеждаме нашите продукти в семейната фабрика в Алгой, Германия.
Научен опит от над 50
години От 1966 година ние в
Töpfer влагаме нашите доказани бифидобактерии в млечните ни формули. Съдържат комплекс от 4 естествени Бифидокултури (B.breve, B.bifidum, B.infantis, B.longum) за
подпомагане на чревната микробиота.
IFO DESIGN
Изисквания
авторите, желаещи
MEDICAl Magazine
СЪДЪРЖАНИЕ
16
20
ТЕХНИКА, ПОКАЗАНИЯ, ПРОТИВОПОКАЗАНИЯ И ПРЕДОТВРАТЯВАНЕ НА УСЛОЖНЕНИЯ Н. Шумка, П. Карагьозов
30 ЕХОЕНДОСКОПСКА ГАСТРОЕНТЕРОАНАСТОМОЗА
2. C. Adlhoch, P. Mook, F. Lamb, L. Ferland, A. Melidou, A.J. Amato-Gauci, et al.Very little influenza in the WHO European Region during the 2020/21 season, weeks 40 2020 to 8 2021 Euro Surveill., 26 (11) (2021), Article 2100221
3. J. VanSummeren, A. Meijer, G. Aspelund, J.S. Casalegno, G. Erna, U. Hoang, et al.Low levels of respiratory syncytial virus activity in Europe during the 2020/21 season: what can we expect in the coming summer and autumn/ winter? Euro Surveill., 26 (29) (2021), Article 2100639
4. Y. Qi, J. Shaman, S. Pei Quantifying the impact of COVID-19 nonpharmaceutical interventions on influenza transmission in the United States J. Infect. Dis., 224 (9) (2021), pp. 1500-1508
5. F. Reicherz, R.Y. Xu, B. AbuRaya, A. Majdoubi, C. Michalski, L. Golding, et
al.Waning immunity against respiratory syncytial virus during the COVID-19 pandemic J. Infect. Dis. (2022), p. jiac192 May 7 6. A. Havasi, S. Visan, C. Cainap, S.S. Cainap, A.A. Mihaila, L.A. Pop Influenza A, influenza B, and SARS-CoV-2 similarities and differences A focus on diagnosisFront. Microbiol., 13 (2022), Article 908525,
7. K. Tone, M. Gochi, K. Kuwano Respiratory syncytial virus pneumonia in an immunocompetent adult: an important differential diagnosis of COVID-19QJM (2022), p. hcac205, Aug 24
8. M.C. Swets, C.D. Russell, E.M. Harrison, A.B. Docherty, N. Lone, M. Girvan, et al. SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses Lancet, 399 (10334) (2022), pp. 1463-1464, 9. Y.W. Tang, J.E. Schmitz, D.H. Persing, C.W. Stratton Laboratory diagnosis of COVID-19: current issues and challenges J. Clin. Microbiol., 58 (6) (2020), pp. e00512-e00520
10. World Health Organization (WHO) Report For the 11th Meeting of the WHO Working Group For the Molecular Detection and Subtyping of Influenza Viruses and the Use of NGS in GISRS
11. R.P. Zuurbier, K. Korsten, T.J.M. Verheij, C. Butler, N. Adriaenssens, S. Coenen, et al. Performance assessment of a rapid molecular respiratory syncytial virus point-of-care test: a prospective community study in older adults J. Infect. Dis., 226 (1) (2022), pp. S63-S70
12. E.J. Chow, J.D. Doyle, T.M. Uyeki Influenza virus-related critical illness: prevention, diagnosis, treatment Crit. Care., 23 (1) (2019), p. 214
13. J.A. Englund, P.A. Piedra, E. Whimbey Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients Am. J. Med., 102 (3A) (1997), pp. 61-70
14. E. Callaway COVID antibody drugs work best when given as early as possible
Nature (2022) Mar 30
15. Paules CI, Marston HD & Fauci
16. NHS. Coronavirus (COVID-19) symptoms. 2020. Available at: https:// www.nhs.uk/conditions/coronaviruscovid-19/symptoms/ (accessed September 2020)
17. Greenhalgh T, Koh GCH & Car J. COVID-19: a remote assessment in primary care. BMJ 2020;368:m1182. doi: 10.1136/bmj.m1182
18. NHS inform. Common cold. 2020. Available at: https://www.nhsinform. scot/illnesses-and-conditions/ infections-and-poisoning/common-cold (accessed September 2020)
19. NHS. Flu. 2019. Available at: https:// www.nhs.uk/conditions/flu/ (accessed September 2020)
20. NHS. Testing and tracing for coronavirus. 2020. Available at: https:// www.nhs.uk/conditions/coronaviruscovid-19/testing-and-tracing/get-atest-to-check-if-you-have-coronavirus/ (accessed September 2020)
AS. Coronavirus infections — more than just the common cold. JAMA 2020;323(8):707–708.
21. World Health Organization. Q&A:
influenza and COVID-19 — similarities and differences. 2020. Available at: https:// www.who.int/westernpacific/news/q-adetail/q-a-similarities-and-differencescovid-19-and-influenza (accessed September 2020)
22. Centers for Disease Control and Prevention. Cold versus flu. 2020. Available at: https://www.cdc.gov/ flu/symptoms/coldflu.htm (accessed September 2020)
23. Royal Pharmaceutical Society. Protecting your team in the pharmacy. 2020. Available at: https://www.rpharms. com/resources/pharmacy-guides/ coronavirus-covid-19/guidance-forpharmacy/protecting-your-team-in-thepharmacy (accessed September 2020)
24. NHS England and NHS Improvement. Novel coronavirus (COVID-19) standard operating procedure — community pharmacy. 2020. Available at: https:// www.england.nhs.uk/coronavirus/ publication/standard-operatingprocedure-community-pharmacy/ (accessed September 2020)
1. Barr, RG (2002). "Changing our understanding of infant colic". Archives of pediatrics & adolescent medicine 156 (12): 1172–4.
2. Catherine Nicole L.A. Ko, Jenny J. Barr, Ronald G. (2008). "Getting the Word Out: Advice on Crying and Colic in Popular Parenting Magazines". Journal of Developmental & Behavioral Pediatrics 29 (6): 508–11.
3. Heyman MB. Lactose Intolerance in Infants, Children, and Adolescents. Pediatrics, 2006, 118 (3): 1279–1286
4. Hogenauer C, Hammer HF. Maldigestion and malabsorption. In: Feldman M,
Friedman LS, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 9th ed. Philadelphia, Pa: Saunders Elsevier; 2010:chap 101. 5. Kaley F, et al. 2011. The psychology of infant colic: A review of current research. Infant Mental Health Journal 32(5):52641. 6. Parker S. Zuckerman B. and Augustyn M. (eds). Developmental and Behavioral Pediatrics: A Handbook for Primary Care. Lippincott Williams and Wilkins, 2005. 7. Savino F, et al. 2010. New treatments for infant colic. Current Opinion in Pediatrics 22(6):791-7
8. Semrad CE. Approach to the patient with diarrhea and malabsorption. In Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 142. 9. Shaukat A. et al. Systematic review: Effective management strategies for lactose intolerance. Annals of Internal Medicine. 2010;152:7978. 10. World Health Organization, UNICEF, Global strategy of infant and young children feeding, Geneva, WHO, 2003 11. World Health Organization, Optimal Duration of Exclusive Breastfeeding, Report of an expert consultation, Geneva, Switzerland, 28-30.03.2001
на анатомичните и физиологични особености на новороде
1. Bayless TM, Rothfeld B, Massa C et al. Lactose and milk intolerance: clinical implication. N Engl J Med, 1975; 292:1156-1159.
2. Salvilahti E, Launiala K, Kuitunen P. Congenital lactase deficiency. Arch Dis Child, 1983; 58:246-252
3. Tuula HV, Marteau P, Korpela R. Lactose intolerance. J Am Coll Nutr, 2000; 2: 165S-175S.
4. http://ncphp.government.bg/files/all-unicef2.pdf
1. Endoscopic ultrasound-guided gastroenterostomy, Int Gastrointest Interv 2022; 11(3): 112-118
2. Endoscopic ultrasound-guided gastrointestinal anastomosis: Are we there yet?, Cesar Jaurrieta-Rico, Vivek Kumar Singh, Digestive Endoscopy 02 May 2024
3. Binmoeller KF, Shah J. A novel lumen-apposing stent for transluminal drainage of nonadherent extraintestinal fluid collections. Endoscopy 2011; 43: 337–342
4. Binmoeller KF, Shah JN. Endoscopic ultrasound-guided gastroenterostomy using novel tools designed for transluminal therapy: A porcine study. Endoscopy 2012; 44: 499–503.
5. Barthet M, Binmoeller KF, Vanbiervliet G, Gonzalez JM, Baron TH, Berdah S. Natural orifice transluminal endoscopic sur-
gery gastroenterostomy with a biflanged lumen-apposing stent: First clinical experience (with videos). Gastrointest Endosc 2015; 81: 215–218.
6. Kiriukova M. de la Iglesia Garcia D, Panie N et al. Pancreatic cancer malnutrition and pancreatic exocrine insufficiency in the course of chemotherapy in unresectable pancreatic cancer. Front Med (Lau-sanne) 2020: 7: 495
7. Perez-Miranda M, Tyberg A, Poletto D, Toscano E, Gaidhane M, Desai AP, et al. EUS-guided gastrojejunostomy versus laparoscopic gastrojejunostomy: an international collaborative study. J Clin Gastroenterol. 2017;51:896-9.
8. Boghossian MB, Funari MP, De Moura DTH, McCarty TR, Sagae VMT, Chen YI, et al. EUS-guided gastroenterostomy ver-
sus duodenal stent placement and surgical gastrojejunostomy for the palliation of malignant gastric outlet obstruction: a systematic review and meta-analysis. Langenbecks Arch Surg. 2021;406:180317. 9. James TW, Greenberg S, Grimm 15 et al. EUS-guided gastroenteric anastomosis as a bridge to definitive treatment in benign gastrie outlet obstruction. Gastrointest Endosc 2020; 91: 537-542
10. Brewer Gutierrez Ol, Irani S5, Ngamruengphong Set al. Endoscopic ultrasound-guided entero-enterostomy for the treatment of affer-ent loop syndrome: a multicenter experience. Endoscopy 2018; 50:891-895
11. Costamagna G, Tringali A, Spicak J, Mutignani M, Shaw J, Roy A, et al.
Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: an international prospective multicentre registry. Dig Liver Dis. 2012;44:37-43.
12. Chen YI, Itoi T, Baron TH, Nieto J, Haito-Chavez Y, Grimm IS, et al. EUS-guided gastroenterostomy is comparable to enteral stenting with fewer re-interventions in malignant gastric outlet obstruction. Surg Endosc. 2017;31:2946-52.
13. Bronswijk M, Vanella G, van Malenstein H et al. Laparoscopic versus EUS-guided gastroenterostomy for gastric outlet obstruction: an international multicenter propensity score-matched comparison (with video). Gastrointest Endosc 2021; 94: 526536.e2
14. Khashab MA, Bukhari M, Baron TH et al.
International multicenter comparative trial of endoscopic ultrasonography-guided gastroen-terostomy versus surgical gastrojejunostomy for the treatment of malignant gastric outlet obstruction. Endosc Int Open 2017; 5:E275-8281
15. Bronswik M, van Malenstein H, Laleman Wet al. EUS-guided gas-troenterostomy. Less is more. The wireless EUS-guided gastroen-terostomy simplified technique VideoGIE 2020; 5: 442
16. Ghandour B et al.Classification, outcomes, and management of misdeployed stents during EUS-guided gastroenterostomy, GIE 2022; 95:80-89
17. Giovani M et al. Assessment of the learning curve for EUS-guided gastroenterostomy for a single operator, GIE 2021; 93:1088-93
HИнфекцията с Helicobacter pylori
предизвиква постоянен имунен отговор, но микроорганизмът има адаптивни механизми за избягване на
ция с Helicobacter pylori при:
- 43% от пациентите ни с функционална диспепсия (ФД).
- 55% от пациентите ни с хроничен гастрит (ХГ).
- 64% от пациентите ни със стомашен аденокарцином (Са).
- 66% от пациентите ни със стомашна язва (СЯ). - 80% от пациентите ни с дуоденална язва (ДЯ).
- 85% от пациентите ни със стомашни полипи (СП).
- 90% от пациентите ни с MALT-лимфом (MALT).
Индикациите за ерадикация на Helicobacter
(Clostridium difficile-обусловен
(Еnterol, Оmnibiotic, Biogaia, Lactacare, Lactoflor и др.) Честотата на страничните
1. Warren JR, Marshall BJ. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:13101314.
2. P Malfertheiner, F Megraud,C A O'Morain, J P Gisbert, E J KUipers, A T Axon, F Bazzoli, A Gasbarrini,J therton, D Graham, R Hunt,P Moayyedi, T Rokkas, M Rugge, M Selgrad, S Suerbaum, K Sugano, E M EI-Omar.
Gut 2016; Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report; 0:1-25. doi:10.1136/ gutjnl-2016-312288.
3. Joseph Adrian L Buensalido, MD et al. Helicobacter pylori Infection Treatment; Medscape; Aug 08, 2014.
4. Michael Selgrad; Jan Bornschein; Peter Malfertheiner. Guidelines for Treatment of Helicobacter pylori in the East and West.
Expert Rev Anti Infect Ther. 2011;9(8):581-588
5. Megraud F. Helicobacter pylori and antibiotic resistance. Gut 56, 1502 (2007) 6. Czinn SJ, Blanchard T. Vaccinating against Helicobacter pylori infection. Nat. Rev. Gastroenterol. Hepatol. 8, 133–140 (2011).
7. Mahachai V, Sirimontaporn N, Tumwasorn S, Thong-Ngam D, Vilaichone RK. Sequential therapy in clarithromycin-sensitive and -resistant Helicobacter pylori based on polymerase chain reaction molecular test. J. Gastroenterol. Hepatol. 26, 825–828 (2011).
8. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59, 1143–1153 (2010).
9. Malfertheiner P, Selgrad M. Helicobacter pylori infection and current clinical areas of contention. Curr. Opin. Gastroenterol. 26, 618–623 (2010).
10. De Francesco V, Giorgio F, Hassan C et al. Worldwide H. pylori antibiotic resistance: a systematic review. J. Gastrointestin. Liver Dis. 19, 409–414 (2010).
11. Siavoshi F, Saniee P, Latifi-Navid S, Massarrat S, Sheykholeslami A. Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline – comparison of three 3-year studies. Arch. Iran. Med. 13, 177–187 (2010).
12. Schwarz S, Morelli G, Kusecek B, et al. Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog 2008; 4:e1000180.
13. Sheila E Crowe. Treatment regimens for Helicobacter pylori; Up to date 2018.
14. Sakurai K, Suda H, Ido Y, et al. Comparative study: Vonoprazan and proton pump
inhibitors in Helicobacter pylori eradication therapy. World J Gastroenterol 2017; 23:668.
Gastroenterology 2016; 151:51.
15. Cao Z, Chen Q, Zhang W, et al. Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial. Scand J Gastroenterol 2015; 50:1185.
16. Hsu PI, Kao SS, Wu DC, et al. A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection. Medicine (Baltimore) 2015; 94:e2104.
17. Peery et al. National Cancer Institute of USA; Gastroenterology, 2015 Dec;149(7):17311741.
18. Fallone CA, Chiba N, van Zanten SV, et al. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
19. Liao WC, Huang MZ, Wang ML, et al. Statin Decreases Helicobacter pylori Burden in Macrophages by Promoting Autophagy. Front Cell Infect Microbiol 2016; 6:203.
20. Murakami K, Sakurai Y, Shiino M, et al. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut 2016; 65:1439.
21. Sakurai K, Suda H, Ido Y, et al. Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy. World J Gastroenterol 2017; 23:668.
22. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol 2017; 112:21.
1. KJ Chang, JB Samarasena, T Iwashita, Y Nakai, JG. Lee Endo-hepatology: a new paradigm Gastrointest Endosc Clin N Am, 22 (2012), pp. 379-385
2. Sbeit W, Kadah A, Mahamid M, Pellicano R, Mari A, Khoury T. A State-of-the-Art Review on the Evolving Utility of Endoscopic Ultrasound in Liver Diseases Diagnosis. Diagnostics (Basel) 2020;10 doi: 10.3390/ diagnostics10080512
3. Iglesias-García J, Lariño-Noia J, Domínguez-Muñoz JE. New Imaging Techniques: Endoscopic Ultrasound-Guided Elastography. Gastrointest Endosc Clin N Am 2017; 27: 551-567
4. Alvarez-Sánchez MV, Napoléon B. Contrast-enhanced harmonic endoscopic ultrasound imaging: basic principles, present situation and future perspectives. World J
Gastroenterol 2014; 20: 15549- 15563 5. Bhogal N, Lamb B, Arbeiter B, Malik S, Sayles H, Lazenby AJ, Chandan S, Dhaliwal A, Singh S, Bhat I. Safety and adequacy of endoscopic ultrasound-guided random liver biopsy in comparison with transjugular and percutaneous approaches. Endosc Int Open. 2020;8:E1850–E1854. doi: 10.1055/a-12749763. 6. Zeng K, Jiang Z, Yang J, Chen K, Lu Q. Role of endoscopic ultrasound-guided liver biopsy: a meta-analysis. Scand J Gastroenterol. 2022;57:545–557. doi: 10.1080/00365521.2021.2025420S
7. Jiang TA, Deng Z, Tian G, Zhao QY, Wang WL. Efficacy and safety of endoscopic ultrasonography-guided interventional treatment for refractory malignant left-sided liver tumors: a case series of 26 patients. Sci
Rep. 2016;6:36098. doi: 10.1038/srep36098 8. Campos S, Poley JW, van Driel L, Bruno MJ. The role of EUS in diagnosis and treatment of liver disorders. Endosc Int Open 2019; 7: E1262-E1275
9. Bhat YM, Weilert F, Fredrick RT, Kane SD, Shah JN, Hamerski CM, Binmoeller KF. EUS-guided treatment of gastric fundal varices with combined injection of coils and cyanoacrylate glue: a large U.S. experience over 6 years (with video) Gastrointest Endosc. 2016;83:1164–1172. doi: 10.1016/j. gie.2015.09.040
10. Binmoeller KF, Weilert F, Shah JN, Kim J. EUS-guided transesophageal treatment of gastric fundal varices with combined coiling and cyanoacrylate glue injection (with videos) Gastrointest Endosc. 2011;74:1019–1025. doi: 10.1016/j.gie.2011.06.030.
11. Huang JY, Samarasena JB, Tsujino T, Lee J, Hu KQ, McLaren CE, Chen WP, Chang KJ. EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study. Gastrointest Endosc. 2017;85:996–1001. doi: 10.1016/j. gie.2016.09.026.
12. Schulman AR, Ryou M, Aihara H, Abidi W, Chiang A, Jirapinyo P, Sakr A, Ajeje E, Ryan MB, Thompson CC. EUS-guided intrahepatic portosystemic shunt with direct portal pressure measurements: a novel alternative to transjugular intrahepatic portosystemic shunting. Gastrointest Endosc 2017; 85: 243-247
14. Chapman CG, Waxman I. Portal-vein blood samples as a new diagnostic entity for pancreatic cancer. Expert Rev Gastroenterol Hepatol 2016; 10: 665-667
15. Park TY, Seo DW, Kang HJ, Song TJ, Park DH, Lee SS, Lee SK, Kim MH. Feasibility and safety of EUS-guided selective portal vein embolization with a coil and cyanoacrylate in a live porcine model. Endosc Ultrasound 2018; 7: 389-394
16. Park TY, Seo DW, Kang HJ, Cho MK, Song TJ, Park DH, Lee SS, Lee SK, Kim MH. Endoscopic ultrasonography-guided placement of a transhepatic portal vein stent in a live porcine model. Endosc Ultrasound 2016; 5: 315-319
13. Liu X, Li C, Li J, Yu T, Zhou G, Cheng J, Li G, Zhou Y, Lou W, Wang X, Gong G, Liu L, Chen Y. Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer. J Cancer 2018; 9: 20382045
